Robinson BW - Search Results

1

Chemotherapy enhances cross-presentation of nuclear tumor antigens.

Anyaegbu CC, Lake RA, Heel K, Robinson BW, Fisher SA. Anyaegbu CC, et al. Among authors: robinson bw. PLoS One. 2014 Sep 22;9(9):e107894. doi: 10.1371/journal.pone.0107894. eCollection 2014. PLoS One. 2014. PMID: 25243472 Free PMC article.

2

Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.

van der Most RG, Currie AJ, Robinson BW, Lake RA. van der Most RG, et al. Among authors: robinson bw. Cell Death Differ. 2008 Jan;15(1):13-20. doi: 10.1038/sj.cdd.4402255. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007666 Review.

3

Harnessing the immune response to treat cancer.

Steer HJ, Lake RA, Nowak AK, Robinson BW. Steer HJ, et al. Among authors: robinson bw. Oncogene. 2010 Dec 2;29(48):6301-13. doi: 10.1038/onc.2010.437. Epub 2010 Sep 20. Oncogene. 2010. PMID: 20856204 Review.

4

Programmed death ligand 2 in cancer-induced immune suppression.

Rozali EN, Hato SV, Robinson BW, Lake RA, Lesterhuis WJ. Rozali EN, et al. Among authors: robinson bw. Clin Dev Immunol. 2012;2012:656340. doi: 10.1155/2012/656340. Epub 2012 Apr 29. Clin Dev Immunol. 2012. PMID: 22611421 Free PMC article. Review.

5

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.

Lesterhuis WJ, Salmons J, Nowak AK, Rozali EN, Khong A, Dick IM, Harken JA, Robinson BW, Lake RA. Lesterhuis WJ, et al. Among authors: robinson bw. PLoS One. 2013 Apr 23;8(4):e61895. doi: 10.1371/journal.pone.0061895. Print 2013. PLoS One. 2013. PMID: 23626745 Free PMC article.

6

Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.

Cleaver AL, Bhamidipaty K, Wylie B, Connor T, Robinson C, Robinson BW, Mutsaers SE, Lake RA. Cleaver AL, et al. Among authors: robinson c, robinson bw. Carcinogenesis. 2014 Feb;35(2):407-14. doi: 10.1093/carcin/bgt322. Epub 2013 Oct 15. Carcinogenesis. 2014. PMID: 24130165

7

The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.

Nelson D, Fisher S, Robinson B. Nelson D, et al. J Immunol Res. 2014;2014:789069. doi: 10.1155/2014/789069. Epub 2014 May 18. J Immunol Res. 2014. PMID: 24955376 Free PMC article. Review.

8

The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40.

Khong A, Cleaver AL, Fahmi Alatas M, Wylie BC, Connor T, Fisher SA, Broomfield S, Lesterhuis WJ, Currie AJ, Lake RA, Robinson BW. Khong A, et al. Among authors: robinson bw. BMC Cancer. 2014 Dec 17;14:969. doi: 10.1186/1471-2407-14-969. BMC Cancer. 2014. PMID: 25518732 Free PMC article.

9

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Creaney J, Ma S, Sneddon SA, Tourigny MR, Dick IM, Leon JS, Khong A, Fisher SA, Lake RA, Lesterhuis WJ, Nowak AK, Leary S, Watson MW, Robinson BW. Creaney J, et al. Among authors: robinson bw. Oncoimmunology. 2015 May 11;4(7):e1011492. doi: 10.1080/2162402X.2015.1011492. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140232 Free PMC article.

10

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.

Lesterhuis WJ, Rinaldi C, Jones A, Rozali EN, Dick IM, Khong A, Boon L, Robinson BW, Nowak AK, Bosco A, Lake RA. Lesterhuis WJ, et al. Among authors: robinson bw. Sci Rep. 2015 Jul 21;5:12298. doi: 10.1038/srep12298. Sci Rep. 2015. PMID: 26193793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page